11. Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy. Issue 2 (10th August 2015) Authors: James, Mark I.; Iwuji, Chinenye; Irving, Glen; Karmokar, Ankur; Higgins, Jennifer A.; Griffin-Teal, Nicola; Thomas, Anne; Greaves, Peter; Cai, Hong; Patel, Samita R.; Morgan, Bruno; Dennison, Ashley; Metcalfe, Matthew; Garcea, Giuseppe; Lloyd, David M.; Berry, David P.; Steward, William P.; Howel... Journal: Cancer letters Issue: Volume 364:Issue 2(2015) Page Start: 135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophagogastric adenocarcinoma. (January 2020) Authors: Thomas, Anne; Virdee, Pradeep S.; Eatock, Martin; Lord, Simon R.; Falk, Stephen; Anthoney, D. Alan; Turkington, Richard C.; Goff, Matthew; Elhussein, Leena; Collins, Linda; Love, Sharon; Moschandreas, Joanna; Middleton, Mark R. Journal: European journal of cancer Issue: Volume 124(2020) Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital. (24th May 2022) Authors: Lee, Rebecca J.; Wysocki, Oskar; Zhou, Cong; Shotton, Rohan; Tivey, Ann; Lever, Louise; Woodcock, Joshua; Albiges, Laurence; Angelakas, Angelos; Arnold, Dirk; Aung, Theingi; Banfill, Kathryn; Baxter, Mark; Barlesi, Fabrice; Bayle, Arnaud; Besse, Benjamin; Bhogal, Talvinder; Boyce, Hayley; Britton... Journal: JCO Clinical Cancer Informatics Issue: Volume 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Evaluation of predictive tools for cell culture clarification performance. Issue 3 (22nd September 2015) Authors: Senczuk, Anna; Petty, Krista; Thomas, Anne; McNerney, Thomas; Moscariello, John; Yigzaw, Yinges Journal: Biotechnology and bioengineering Issue: Volume 113:Issue 3(2016) Page Start: 568 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Final results and outcomes by prior bevacizumab exposure, skin toxicity, and hypomagnesaemia from ASPECCT: randomized phase 3 non-inferiority study of panitumumab versus cetuximab in chemorefractory wild-type KRAS exon 2 metastatic colorectal cancer. (November 2016) Authors: Price, Timothy; Kim, Tae Won; Li, Jin; Cascinu, Stefano; Ruff, Paul; Suresh, Attili Satya; Thomas, Anne; Tjulandin, Sergei; Guan, Xuesong; Peeters, Marc Journal: European journal of cancer Issue: Volume 68(2016) Page Start: 51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Frequency of S492R mutations in the epidermal growth factor receptor: analysis of plasma DNA from patients with metastatic colorectal cancer treated with panitumumab or cetuximab monotherapy. Issue 10 (2nd October 2020) Authors: Price, Timothy; Ang, Agnes; Boedigheimer, Michael; Kim, Tae Won; Li, Jin; Cascinu, Stefano; Ruff, Paul; Satya Suresh, Attili; Thomas, Anne; Tjulandin, Sergei; Peeters, Marc Journal: Cancer biology & therapy Issue: Volume 21:Issue 10(2020) Page Start: 891 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Home infusions of natalizumab for people with multiple sclerosis: a pilot randomised crossover trial. Issue 8 (21st July 2021) Authors: Schultz, Timothy J.; Thomas, Anne; Georgiou, Paul; Juaton, Mahasen S.; Cusack, Lynette; Simon, Lorraine; Naidoo, Kerisha; Webb, Kevin; Karnon, Jonathan; Ravindran, Janakan Journal: Annals of clinical and translational neurology Issue: Volume 8:Issue 8(2021) Page Start: 1610 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. In Vitro Secretion Deficits are Common Among Human Coagulation Factor XIII Subunit B Missense Mutants: Correlations with Patient Phenotypes and Molecular Models. Issue 11 (13th September 2013) Authors: Biswas, Arijit; Thomas, Anne; Bevans, Carville G.; Ivaskevicius, Vytautas; Oldenburg, Johannes Journal: Human mutation Issue: Volume 34:Issue 11(2013:Nov.) Page Start: 1490 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. In Vitro Secretion Deficits are Common Among Human Coagulation Factor XIII Subunit B Missense Mutants: Correlations with Patient Phenotypes and Molecular Models. Issue 11 (13th September 2013) Authors: Biswas, Arijit; Thomas, Anne; Bevans, Carville G.; Ivaskevicius, Vytautas; Oldenburg, Johannes Journal: Human mutation Issue: Volume 34:Issue 11(2013:Nov.) Page Start: 1490 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Inequalities in cancer screening, prevention and service engagement between UK ethnic minority groups. (26th May 2022) Authors: Abraham, Shalin; Foreman, Nalini; Sidat, Zahirah; Sandhu, Pavandeep; Marrone, Domenic; Headley, Catherine; Akroyd, Carol; Nicholson, Sarah; Brown, Karen; Thomas, Anne; Howells, Lynne M; Walter, Harriet S Journal: British journal of nursing Issue: Volume 31:Number 10(2022) Page Start: S14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗